Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Optimizing treatment success in multiple sclerosis.
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Retinal periphlebitis is associated with multiple sclerosis severity.
Electrodiagnostic evaluation of peripheral nervous system changes in patients with multiple sclerosis.
Significant association of interleukin-4 gene intron 3 VNTR polymorphism with susceptibility to knee osteoarthritis.
On the role of natural killer cells in neurodegenerative diseases.
Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis.
Cerebrospinal fluid proteomics in multiple sclerosis.
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.
Age-related changes in spleen of Dark Agouti rats immunized for experimental autoimmune encephalomyelitis.
Placebo and nocebo effects in the neurological practice.
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses.
[Neuropathology of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy].
Interferon beta-associated recurrence of painful trigeminal neuropathy attributed to a multiple sclerosis plaque.
Nitric oxide-induced neuronal to glial lineage fate-change depends on NRSF/REST function in neural progenitor cells.
Early predictors of multiple sclerosis after a typical clinically isolated syndrome.
miR-20b Suppresses Th17 Differentiation and the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting RORγt and STAT3.
Diazoxide Attenuates Autoimmune Encephalomyelitis and Modulates Lymphocyte Proliferation and Dendritic Cell Functionality.
The role of antiproliferative gene Tob1 in the immune system.
Sphingosine-1-phosphate receptor inhibition prevents denervation-induced dendritic atrophy.
Kif13b Regulates PNS and CNS Myelination through the Dlg1 Scaffold.
Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.
Analytical performances of SPAPLUS® turbidimeter for the quantification of albumin and IgG in serum and cerebrospinal fluid.
Pages
« first
‹ previous
…
504
505
506
507
508
509
510
511
512
…
next ›
last »